Your browser doesn't support javascript.
loading
SerpinC1/Antithrombin III in kidney-related diseases.
Lu, Zeyuan; Wang, Feng; Liang, Mingyu.
Afiliação
  • Lu Z; Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Wang F; Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A.
  • Liang M; Center of Systems Molecular Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A.
Clin Sci (Lond) ; 131(9): 823-831, 2017 May 01.
Article em En | MEDLINE | ID: mdl-28424376
ABSTRACT
The gene SerpinC1 encodes a serine protease inhibitor named antithrombin III (ATIII). This protease demonstrates both anticoagulant and anti-inflammatory action. ATIII is the most important coagulation factor inhibitor, and even minor changes in ATIII can significantly alter the risk of thromboembolism. ATIII can also suppress inflammation via a coagulation-dependent or -independent effect. Moreover, apart from ATIII deficiency, ATIII and its gene SerpinC1 may also be related to many diseases (e.g. hypertension, kidney diseases). The present review summarizes how ATIII affects the progress of kidney disease and its mechanism. Further studies are required to investigate how ATIII affects renal function and the treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia / Antitrombina III / Deficiência de Antitrombina III / Nefropatias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Sci (Lond) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia / Antitrombina III / Deficiência de Antitrombina III / Nefropatias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Sci (Lond) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China